Open AccessPhase 1 trial for treatment of COVID‐19 patients with pulmonary fibrosis using hESC‐IMRCs
Author(s) -
Wu Jun,
Zhou Xing,
Tan Yuanqing,
Wang Liu,
Li Tianda,
Li Zhongwen,
Gao Tingting,
Fan Jiaqi,
Guo Baojie,
Li Wei,
Hao Jie,
Wang Xianguang,
Hu Baoyang
Publication year - 2020
Publication title -
cell proliferation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.647
H-Index - 74
eISSN - 1365-2184
pISSN - 0960-7722
DOI - 10.1111/cpr.12944
Subject(s) - pulmonary fibrosis , medicine , oxygen therapy , fibrosis , lung , covid-19 , respiratory system , complication , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom